|
Home
Potential
clients
My
work
Client
results
Research
Published
papers
Guest
lectures
They
said it!
Resources
Contact
|
|
|
|
|
|
|
Cytyc's
Impact on Women's Health
Medical
Development Group (MDG)
Ralph E.
Grabowski, panelist
|
|
|
|
|
Contents
|
|
New
data
This
invited presentation was delivered at the beginning of the Medical Development Group's
sixth year as a professional organization. In honor of the MDG,
I published new evidence, the eightieth data point, from my research into the Marketing/Engineering
Investment Ratio™ (M/E Ratio™).
View
all the data on page 2 of the MDG
forum handout - PDF,
2 pages, 0.35 MB
|
|
|
M/E |
|
a
Failure |
|
|
|
0.07 |
|
Orchid
BioSciences, genotyping 1998
http://www.orchid.com/overview/index.asp
In
the early 2000s, as Cytyc's market capitalization was soaring to $3.65
Billion, Orchid BioSciences' market capitalization was plummeting
from $3.3 Billion to $19 million.
|
|
|
|
|
|